SCHEMBL17290652

SCHEMBL17290652

CON=C(C)C1(NO)C(=O)N(c2ccccc2)N=C1C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOX P28300 1/20 0.35
ATM Q13315 1/20 0.34
GAA P10253 6/20 0.33
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 2/20 0.33
POLB P06746 2/20 0.31
RECQL P46063 2/20 0.31
BLM P54132 1/20 0.31
LMNA P02545 1/20 0.30
PKM P14618 1/20 0.30
HTT P42858 1/20 0.30
MAPK13 O15264 3/20 0.30
MAPK12 P53778 3/20 0.30
MAPK11 Q15759 3/20 0.30
MAPK14 Q16539 3/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17290650 1.00 LOX (0.35) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL14886859 0.85 SMN1; SMN2 (0.42) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17290667 0.85 SMN1; SMN2 (0.42) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17295086 0.84 GAA (0.34) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17290753 0.84 GAA (0.34) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17290754 0.84 GAA (0.34) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17290507 0.82 GAA (0.33) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290510 0.82 GAA (0.33) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290444 0.81 LOX (0.36) LOXATMGAAALDH1A1L3MBTL1
SCHEMBL17295138 0.81 LOX (0.36) LOXATMGAAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US claimed
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 LOX 911/4885ATM 1203/4885GAA 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.